These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7911563)

  • 21. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma.
    Thomas AA; Rini BI; Lane BR; Garcia J; Dreicer R; Klein EA; Novick AC; Campbell SC
    J Urol; 2009 Feb; 181(2):518-23; discussion 523. PubMed ID: 19100579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
    Waldert M; Klatte T; Haitel A; Ozsoy M; Schmidbauer J; Marberger M; Remzi M
    Eur Urol; 2010 Apr; 57(4):661-5. PubMed ID: 19477583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circumvention of multidrug resistance mediated by P-170 glycoprotein using calcium antagonists in primary human renal cell carcinoma.
    Mickisch GH; Kössig J; Tschada RK; Keilhauer G; Schlick E; Alken PM
    Urol Int; 1991; 47(3):118-25. PubMed ID: 1685271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Claudins as prognostic factors for renal cell cancer.
    Virman J; Soini Y; Kujala P; Luukkaala T; Salminen T; Sunela K; Kellokumpu-Lehtinen PL
    Anticancer Res; 2014 Aug; 34(8):4181-7. PubMed ID: 25075044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma.
    Toma MI; Weber T; Meinhardt M; Zastrow S; Grimm MO; Füssel S; Wirth MP; Baretton GB
    Cancer Invest; 2011 Feb; 29(2):123-9. PubMed ID: 21210727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma.
    Anastassiou G; Duensing S; Steinhoff G; Zorn U; Grosse J; Dallmann I; Kirchner H; Ganser A; Atzpodien J
    Oncology; 1996; 53(2):127-32. PubMed ID: 8604238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
    Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis.
    Fu Q; Chang Y; An H; Fu H; Zhu Y; Xu L; Zhang W; Xu J
    Br J Cancer; 2015 Dec; 113(11):1581-9. PubMed ID: 26554658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
    Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
    J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma.
    Lehmann J; Retz M; Nürnberg N; Schnöckel U; Raffenberg U; Krams M; Kellner U; Siemer S; Weichert-Jacobsen K; Stöckle M
    Cancer; 2004 Oct; 101(7):1552-62. PubMed ID: 15378494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis.
    Bex A; Haanen JB; Vyth-Dreese FA; Horenblas S; de Gast GC
    Urol Int; 2008; 80(4):367-71. PubMed ID: 18587246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycoprotein non-metastatic melanoma protein B as a predictive prognostic factor in clear-cell renal cell carcinoma following radical nephrectomy.
    Qin C; Liu Z; Yuan Y; Zhang X; Li H; Zhang C; Xu T; Wang X
    Mol Med Rep; 2014 Mar; 9(3):851-6. PubMed ID: 24425288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women.
    Trpkov K; Hes O; Bonert M; Lopez JI; Bonsib SM; Nesi G; Comperat E; Sibony M; Berney DM; Martinek P; Bulimbasic S; Suster S; Sangoi A; Yilmaz A; Higgins JP; Zhou M; Gill AJ; Przybycin CG; Magi-Galluzzi C; McKenney JK
    Am J Surg Pathol; 2016 Jan; 40(1):60-71. PubMed ID: 26414221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.
    Erdem S; Yegen G; Telci D; Yildiz I; Tefik T; Issever H; Kilicaslan I; Sanli O
    World J Urol; 2015 Oct; 33(10):1553-60. PubMed ID: 25515319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas expression in renal cell carcinoma accurately predicts patient survival after radical nephrectomy.
    Sejima T; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
    Urol Int; 2012; 88(3):263-70. PubMed ID: 22398398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.
    Bazzi WM; Sjoberg DD; Feuerstein MA; Maschino A; Verma S; Bernstein M; O'Brien MF; Jang T; Lowrance W; Motzer RJ; Russo P
    J Urol; 2015 Jun; 193(6):1911-6. PubMed ID: 25524244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.